References
[1] Moulik NR, Parveen F, Kumar A, et al. Glutathione-Stransferase polymorphismand and acute lymphoblastic leukemia (ALL) in north Indian children:a case-control study and metaanalysis[J]. J Hum Genet, 2014, 59(9):529-535.
[2] Li X, Liao Q, Zhang S, et al. Association of methylenetetrahytrofolate reductase (MTHFR) C677T and A1298C polymorphisms with the susceptibility of childhood acute lymphoblastic leukaemia (ALL) in Chinese population[J]. Eur J Med Res, 2014, 19(1):5.
[3] Margulis AV, Pladevall M, Riera-Guardia N, et al. Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools:the Newcastle-Ottawa Scale and the RTI item bank[J]. Clin Epidemiol, 2014, 6:359-368.
[4] Krajinovic M, Labuda D, Richer C, et al. Susceptibility to childhood acute lymphoblastic leukemia:influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms[J]. Blood, 1999, 93(5):1496-1501.
[5] Balta G, Yuksek N, Ozyurek E, et al. Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes in childhood acute leukemia[J]. Am J Hematol, 2003, 73(3):154-160.
[6] 高建平, 黄跃东, 梁建平, 等. CYP1A1 基因多态性与急性淋巴细胞白血病的关系[J]. 中国优生与遗传杂志, 2003, 11(5):21-24.
[7] Joseph T, Kusumakumary P, Chacko P, et al. Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children[J]. Pediatr Blood Cancer, 2004, 43(5):560-567.
[8] Canalle R, Burim RV, Tone LG, et al. genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia[J]. Environ Mol Mutagen, 2004, 43(2):100-109.
[9] Clavel J, Bellec S, Rebouissou S, et al. Childhood leukaemia, polymorphisms of metabolism enzyme genes, and interactions with maternal tobacco, coffee and alcohol consumption during pregnancy[J]. Eur J Cancer Prev, 2005, 14(6):531-540.
[10] Aydin-Sayitoglu M, Hatirnaz O, Erensoy N, et al. Role of cyp2d6, cyp1a1, cyp2e1, gstt1, and gstm1 genes in the susceptibility to acute leukemias[J]. Am J Hematol, 2006, 81(3):162-170.
[11] Lee KM, Ward MH, Han S, et al. Paternal smoking, genetic polymorphisms in CYP1A1 and childhood leukemia risk[J]. Leuk Res, 2009, 33(2):250-258.
[12] Yamaguti GG, Lourenço GJ, Silveira VS, et al. Increased risk for acute lymphoblastic leukemia in children with cytochrome p450a1 (cyp1a1)-and nad(p)h_quinone oxidoreductase 1 (nqo1)-inherited gene variants[J]. Acta Haematol, 2010, 124(3):182-186.
[13] Swinney RM, Beuten J, Collier AB 3rd, et al. Polymorphisms in CYP1A1 and ethnic-specific susceptibility to acute lymphoblastic leukemia in children[J]. Cancer Epidemiol Biomarkers Prev, 2011, 20(7):1537-1542.
[14] Suneetha KJ, Nancy KN, Rajalekshmy KR, et al. Role of glutathione-s-transferase and CYP1A1*2A polymorphisms in the therapy outcome of south Indian acute lymphoblastic leukemia patients[J]. Indian J Med Paediatr Oncol, 2011, 32(1):25-29.
[15] Agha A, Shabaan H, Abdel-Gawad E, et al. Polymorphism of CYP1A1 gene and susceptibility to childhood acute lymphoblastic leukemia in Egypt[J]. Leuk Lymphoma, 2014, 55(3):618-623.
[16] Liu C, Jiang Z, Deng QX, et al. Meta-analysis of association studies of CYP1A1 genetic polymorphisms with digestive tract cancer susceptibility in Chinese[J]. Asian Pac J Cancer Prev, 2014, 15(11):4689-4695.
[17] Zhan P, Wang Q, Qian Q, et al. CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk:an updated meta-analysis and review[J]. J Exp Clin Cancer Res, 2011, 30:99.
[18] Steffen C, Auclerc MF, Auvrignon A, et al. Acute childhood leukaemia and environmental exposure to potential sources of benzene and other hydrocarbons:a case-control study[J]. Occup Environ Med, 2004, 61(9):773-778.
[19] Han F, Tan Y, Cui W, et al. Novel insights into etiologies of leukemia:a HuGE review and meta-analysisof CYP1A1 polymorphisms and leukemia risk[J]. Am J Epidemiol, 2013, 178(4):493-507.
[20] Voso MT, D'Alo' F, Gumiero D, et al. The CYP1A1*2a allele is an independent prognostic factor for acute myeloid leukemia[J]. Haematologica, 2005, 90(7):982-984.
[21] Krajinovic M, Labuda D, Mathonnet G, et al. Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia1[J]. Clin Cancer Res, 2002, 8(3):802-810.